Evidence map›Paper›PMID 41796145›Full record

ArticleScientific reports2026

Microwave assisted synthesis and antimicrobial evaluation of novel Thiazolidinedione pyrrole hybrids with antiviral potential and comprehensive computational modeling studies.

Ragini C Patil, Mohamed Abdel-Megid, Nita M Khiratkar, Sumeer Ahmed, Arif Hussain, Murugesan Sankaranarayanan, Pranali Vijaykumar Kuthe, Senthil Kumar Raju, Muatz Salih, Ajmal R Bhat and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ragini C PatilDepartment of Chemistry, Rashtrapita Mahatma Gandhi Arts, Commerce, and Science College Saoli, Gondwana University Gadchiroli, (Maharashtra), District Chandrapur, 441225, India.
Mohamed Abdel-MegidChemistry Department, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11623, Saudi Arabia.
Nita M KhiratkarDepartment of Chemistry, Institutions of Higher Learning, Research and Specialized Studies, Dr. Ambedkar College of Arts, Commerce and Science, Gondwana University Gadchiroli, (Maharashtra), Chandrapur, 442401, India.
Sumeer AhmedNatural Products and Medicinal Chemistry Division, CSIR - Indian Institute of Integrative Medicine Jammu, Jammu Tawi, 180 001, India.
Arif HussainSchool of Life Sciences, Manipal Academy of Higher Education, Dubai, UAE. dr.arifhussain@yahoo.co.in.
Murugesan SankaranarayananMedicinal Chemistry Research Laboratory, Department of Pharmacy, Birla Institute of Technology and Science Pilani, Pilani Campus, Pilani, Rajasthan, 333031, India.
Pranali Vijaykumar KutheMedicinal Chemistry Research Laboratory, Department of Pharmacy, Birla Institute of Technology and Science Pilani, Pilani Campus, Pilani, Rajasthan, 333031, India.
Senthil Kumar RajuDepartment of Pharmaceutical Chemistry, Swamy Vivekanandha College of Pharmacy, Tiruchengode, 637 205, Tamil Nadu, India.
Muatz SalihChemistry Department, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11623, Saudi Arabia.
Ajmal R BhatDepartment of Chemistry, RTM Nagpur University, Nagpur, 440033, India. bhatajmal@gmail.com.
Mostafa E SalemChemistry Department, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11623, Saudi Arabia.

Funding

This work was supported and funded by the Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University (IMSIU) IMSIU-DDRSP2601
6 · The paper itself

Abstract

A novel class of N-substituted thiazolidine-2,4-dione/pyrrole-2,5-dione moiety derivatives 3(a–g) was synthesized via C–N bond formation through SN2-mediated reaction, utilizing microwave-assisted synthesis to enhance reaction efficiency and product yield. This approach enabled the rapid and selective formation of the target compounds, which were evaluated for their in vitro antimicrobial activity against a variety of bacterial and fungal strains. The compounds demonstrated promising antibacterial and antifungal properties, with compound 3g showing the highest activity, producing significant inhibition zones against Gram-negative strains (E. coli and P. aeruginosa) as well as Gram-positive strains (S. aureus and B. subtilis). To further validate and refine the docking outcomes, molecular dynamics (MD) simulations were performed, providing detailed insights into the dynamic stability, conformational adaptability, hydrogen-bond persistence, and overall binding energetics of the most promising ligand–protein complexes. Density functional theory (DFT) calculations provided valuable insights into the electronic properties, stability, and reactivity of the compounds. The study successfully identified targeted compounds exhibiting significant antiviral/anti–SARS-CoV-2 potential using the pharmacophore POM model, highlighting their predicted ability to inhibit crucial viral proteins. The structures of the synthesized compounds were confirmed using a range of spectroscopic techniques, including FT IR, 1H NMR, 13C NMR, and mass spectrometry, ensuring the successful synthesis of the bioactive derivatives.

Indexed as

Anti-Infective AgentsAntiviral AgentsMicrowavesPyrrolesThiazolidinedionesAnti-Bacterial AgentsMicrobial Sensitivity TestsMolecular Docking SimulationMolecular Dynamics SimulationAnti-Bacterial AgentsAnti-Infective AgentsAntiviral AgentsPyrrolesthiazolidine-2,4-dioneThiazolidinedionesAntiviral / Anti–SARS-CoV-2 potentialIn vitro antimicrobial activity, computational insightsMicrowave synthesisN-substituted thiazolidine-2,4-dionePyrrole-2,5-dione

Identifiers

PMID41796145
PMCPMC13057015

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.